You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 17, November 7, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS

S. Gartner, P. Markovits, D. M. Markovitz, R. F. Betts and M. Popovic

Primary cultures from a brain biopsy specimen of a human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) seropositive patient with progressive dementia contained small numbers of monocytoid cells and showed reverse transcriptase activity that persisted for as long as 100 days. Electron microscopy of these cells revealed the presence of HTLV-III/LAV virions. Subcultured cells removed from primary cultures by trypsinization were nonspecific esterase negative and did not express virus or show evidence of HTLV-III/LAV proviral sequences, while those remaining in the original flasks were nonspecific esterase positive and continued to produce virus. Virus from primary cultures was transmitted to peripheral blood-derived monocyte-macrophages and T cells. Virus production in T-cell cultures was transient while the monocyte-macrophages, like the primary cultures, produced virus for at least 120 days. Infection of several brain-derived cells with this and another HTLV-III/LAV isolate failed to demonstrate virus replication. These results indicate that the HTLV-III/LAV-infected cells recovered from the brain of this patient are cells of the mononuclear phagocyte series.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV-1 Tat Interactions with p300 and PCAF Transcriptional Coactivators Inhibit Histone Acetylation and Neurotrophin Signaling through CREB
Wong et al.
J. Biol. Chem. 2005;280:9390-9399.
ABSTRACT | FULL TEXT  

Antiviral Activity of CYC202 in HIV-1-infected Cells
Agbottah et al.
J. Biol. Chem. 2005;280:3029-3042.
ABSTRACT | FULL TEXT  

Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2'F-RNA Aptamers
Khati et al.
J. Virol. 2003;77:12692-12698.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus Type 1 Infection and Replication in Normal Human Oral Keratinocytes
Liu et al.
J. Virol. 2003;77:3470-3476.
ABSTRACT | FULL TEXT  

Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity
Gorry et al.
J. Virol. 2001;75:10073-10089.
ABSTRACT | FULL TEXT  

Lipopolysaccharide stimulates HIV-1 entry and degradation in human macrophages
Pushkarsky et al.
Innate Immunity 2001;7:271-276.
ABSTRACT  

Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation
Esser et al.
J. Virol. 2001;75:6173-6182.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.